Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | August 14, 2012 | August 16, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GILEAD SCIENCES, INC.
Report date August 14, 2012 · Filed August 16, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Trust | 907,839 |
Reported balance
After 2012-08-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2012-08-14 · Exercise / conversion · Acquired 96,000 · Balance 907,839 |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 1,003,839 |
Reported balance
After 2012-08-14 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2012-08-14 · Exercise / conversion · Acquired 96,000 · Balance 1,003,839 |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 1,063,839 |
Reported balance
After 2012-08-14 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2012-08-14 · Exercise / conversion · Acquired 60,000 · Balance 1,063,839 |
| Non-Qualified Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.50 · Expires 2013-01-02 | Direct | 0 |
Reported balance
After 2012-08-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2012-08-14 · Exercise / conversion · Disposed 96,000 · Balance 0 F1: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. |
| Non-Qualified Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.70 · Expires 2014-05-25 | Direct | 0 |
Reported balance
After 2012-08-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2012-08-14 · Exercise / conversion · Disposed 96,000 · Balance 0 F2: Options are 100% vested on the date of grant. |
| Non-Qualified Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.44 · Expires 2015-05-10 | Direct | 0 |
Reported balance
After 2012-08-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2012-08-14 · Exercise / conversion · Disposed 60,000 · Balance 0 F2: Options are 100% vested on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F2: Options are 100% vested on the date of grant.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTEL CORP
Report date March 02, 2005 · Filed March 03, 2005
Section 16 reporting ended · disclosed 2005-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMONSEC Table I · non-derivative | IndirectTrust for Self and Spouse | 172,989,055 |
Reported balance
After 2005-03-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2005-03-02 · Gift · Disposed 1,000,000 · Balance 172,989,055 F1: Not a required reportable field. SEC software requires a dollar amount; use zeros per SEC. |
| COMMONSEC Table I · non-derivative | Direct | 3,302 |
Reported balance
Holding disclosure · report date 2005-03-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,302 |
Filing footnotes · ownership attribution and instrument terms
F1: Not a required reportable field. SEC software requires a dollar amount; use zeros per SEC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2012 Filed Aug 16, 2012 20:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 60,000 | $0.00 Strike: $19.44 | $0.00 |
DisclosureSEC source: 0001179110-12-012994 · edgar.xml · derivative · entry 6 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2015-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are 100% vested on the date of grant. Read SEC document |
| August 14, 2012 Filed Aug 16, 2012 20:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 96,000 | $0.00 Strike: $15.70 | $0.00 |
DisclosureSEC source: 0001179110-12-012994 · edgar.xml · derivative · entry 5 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,000 shares Expires 2014-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are 100% vested on the date of grant. Read SEC document |
| August 14, 2012 Filed Aug 16, 2012 20:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 96,000 | $0.00 Strike: $8.50 | $0.00 |
DisclosureSEC source: 0001179110-12-012994 · edgar.xml · derivative · entry 4 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,000 shares Expires 2013-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. Read SEC document |
| August 14, 2012 Filed Aug 16, 2012 20:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 60,000 | $19.44 | $1,166,100.00 |
DisclosureSEC source: 0001179110-12-012994 · edgar.xml · nonDerivative · entry 3 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 1,063,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2012 Filed Aug 16, 2012 20:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 96,000 | $15.70 | $1,507,200.00 |
DisclosureSEC source: 0001179110-12-012994 · edgar.xml · nonDerivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 1,003,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2012 Filed Aug 16, 2012 20:32 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 96,000 | $8.50 | $816,000.00 |
DisclosureSEC source: 0001179110-12-012994 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 907,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2012 Filed May 16, 2012 00:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 3,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-12-008471 · edgar.xml · derivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,926 Underlying: Common Stock · 3,632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 12, 2012, at the end of the first year of service. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 12, 2012, at the end of the first year of service. Read SEC document |
| May 12, 2012 Filed May 16, 2012 00:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 3,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-12-008471 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 10, 2012 Filed May 15, 2012 00:24 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 2,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-12-008421 · edgar.xml · derivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,558 Underlying: Common Stock · 2,926 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 10, 2013, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 10, 2013, at the end of the first year of service. Read SEC document |
| May 10, 2012 Filed May 15, 2012 00:24 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 8,161 | $0.00 Strike: $51.25 | $0.00 |
DisclosureSEC source: 0001179110-12-008421 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,161 Underlying: Common Stock · 8,161 shares Expires 2022-05-10 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 10, 2013. Read SEC document |
| November 11, 2011 Filed Nov 15, 2011 21:22 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 96,000 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0001179110-11-015188 · edgar.xml · derivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,000 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options have a 5 year vesting schedule. 5% of the options vested on April 2, 2002, and the balance vested 5% every three months thereafter until fully vested on January 2, 2007. The options expire on January 2, 2012. Read SEC document |
| November 11, 2011 Filed Nov 15, 2011 21:22 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 96,000 | $8.22 | $788,640.00 |
DisclosureSEC source: 0001179110-11-015188 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 811,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2011 Filed May 14, 2011 01:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 3,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-11-007989 · edgar.xml · derivative · entry 4 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,632 Underlying: Common Stock · 3,632 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 12, 2012, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 12, 2012, at the end of the first year of service. Read SEC document |
| May 12, 2011 Filed May 14, 2011 01:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 10,141 | $0.00 Strike: $41.29 | $0.00 |
DisclosureSEC source: 0001179110-11-007989 · edgar.xml · derivative · entry 3 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,141 Underlying: Common Stock · 10,141 shares Expires 2021-05-12 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 12, 2012. Read SEC document |
| May 11, 2011 Filed May 14, 2011 01:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 3,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-11-007989 · edgar.xml · derivative · entry 5 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F4 · derivative.exercise_date: 100% of the restricted stock units vested on May 11, 2011, at the end of the first year of service. F4 · derivative.expiration_date: 100% of the restricted stock units vested on May 11, 2011, at the end of the first year of service. Read SEC document |
| May 11, 2011 Filed May 14, 2011 01:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 3,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-11-007989 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| August 19, 2010 Filed Aug 23, 2010 22:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 144,000 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001179110-10-013076 · edgar.xml · derivative · entry 3 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,000 shares Expires 2011-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested in quarterly installments beginning April 2, 2001 and were fully vested on January 2, 2006. Read SEC document |
| August 19, 2010 Filed Aug 23, 2010 22:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 144,000 | $5.18 | $746,438.40 |
DisclosureSEC source: 0001179110-10-013076 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 715,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2010 Filed May 13, 2010 23:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 3,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-008589 · edgar.xml · derivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,820 Underlying: Common Stock · 3,820 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 11, 2011, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 11, 2011, at the end of the first year of service. Read SEC document |
| May 11, 2010 Filed May 13, 2010 23:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 10,860 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001179110-10-008589 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,860 Underlying: Common Stock · 10,860 shares Expires 2020-05-11 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 11, 2011. Read SEC document |
| May 06, 2010 Filed May 10, 2010 21:47 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 3,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-008260 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 702,046 F1 · shares: Issuance of common stock upon vesting of certain restricted share units on May 6, 2010. Read SEC document |
| August 07, 2009 Filed Aug 11, 2009 21:08 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 144,000 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001179110-09-011932 · edgar.xml · derivative · entry 4 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,000 shares Expires 2010-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested in quarterly installments beginning April 3, 2000 and were fully vested on January 3, 2005. Read SEC document |
| August 07, 2009 Filed Aug 11, 2009 21:08 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 33,183 | $3.38 | $112,254.77 |
DisclosureSEC source: 0001179110-09-011932 · edgar.xml · nonDerivative · entry 3 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 571,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2009 Filed Aug 11, 2009 21:08 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 110,817 | $46.07 | $5,104,873.76 |
DisclosureSEC source: 0001179110-09-011932 · edgar.xml · nonDerivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 698,640 F2 · price: Sales prices reported for the transactions reported here range from $46.00 to $46.1901. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| August 07, 2009 Filed Aug 11, 2009 21:08 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 110,817 | $3.38 | $374,882.83 |
DisclosureSEC source: 0001179110-09-011932 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2009 Filed May 8, 2009 22:58 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 3,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-09-007481 · edgar.xml · derivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,406 Underlying: Common Stock · 3,406 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 6, 2010, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 6, 2010, at the end of the first year of service. Read SEC document |
| May 06, 2009 Filed May 8, 2009 22:58 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 9,534 | $0.00 Strike: $44.03 | $0.00 |
DisclosureSEC source: 0001179110-09-007481 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,534 Underlying: Common Stock · 9,534 shares Expires 2019-05-06 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 6, 2010. Read SEC document |
| July 30, 2008 Filed Jul 31, 2008 17:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 144,000 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001179110-08-014316 · edgar.xml · derivative · entry 3 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,000 shares Expires 2009-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested in quarterly installments beginning April 2, 1999 and were fully vested on January 2, 2004. Read SEC document |
| July 30, 2008 Filed Jul 31, 2008 17:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 144,000 | $2.57 | $369,576.00 |
DisclosureSEC source: 0001179110-08-014316 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 288,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2008 Filed Jan 9, 2009 01:28 UTC Amendment | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 144,000 | $2.57 | $369,576.00 |
DisclosureSEC source: 0001179110-09-000846 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 538,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2008 Filed May 9, 2008 23:15 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (right to buy) · Derivative | 26,250 | $0.00 Strike: $53.23 | $0.00 |
DisclosureSEC source: 0001179110-08-009317 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2018-05-08 F1 · derivative.exercise_date: Options vest quarterly over a period of one year from date of grant. Read SEC document |
| September 07, 2007 Filed Sep 11, 2007 21:59 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 144,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001179110-07-018125 · edgar.xml · derivative · entry 3 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,000 shares Expires 2007-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested in quarterly installments beginning April 2, 1998 and were fully vested on January 2, 2003. Read SEC document |
| September 07, 2007 Filed Sep 11, 2007 21:59 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 144,000 | $2.39 | $344,260.80 |
DisclosureSEC source: 0001179110-07-018125 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 144,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2007 Filed May 11, 2007 23:07 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 26,250 | $0.00 Strike: $82.82 | $0.00 |
DisclosureSEC source: 0001179110-07-009851 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2017-05-09 F1 · derivative.exercise_date: Options vested in full on May 9, 2007, the date of grant. Read SEC document |
| February 21, 2007 Filed Feb 23, 2007 00:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $3.28 | $0.00 |
DisclosureSEC source: 0001179110-07-004571 · edgar.xml · derivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2007-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Granted pursuant to the Gilead Sciences, Inc. 1995 Non-Employee Directors Stock Option Plan in a transaction exempt from Rule 16b-3. F1 · derivative.exercise_date: Options vested in equal quarterly installments over a five-year period beginning on date of grant, April 14, 1997. The option was fully vested as of April 14, 2002. Read SEC document |
| February 21, 2007 Filed Feb 23, 2007 00:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 16,000 | $3.28 | $52,500.80 |
DisclosureSEC source: 0001179110-07-004571 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2006 Filed Oct 21, 2006 01:13 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 56,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001179110-06-020178 · edgar.xml · derivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,000 shares Expires 2007-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested 5% every quarter beginning date of grant on 1/2/97. The options were fully vested as of 1/2/02. Read SEC document |
| October 19, 2006 Filed Oct 21, 2006 01:13 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 56,000 | $3.13 | $175,000.00 |
DisclosureSEC source: 0001179110-06-020178 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2006 Filed May 12, 2006 00:46 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 26,250 | $0.00 Strike: $57.35 | $0.00 |
DisclosureSEC source: 0001179110-06-010651 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2016-05-10 F1 · kind: Options are granted as part of the annual compensation to non-employee members of the Board of Directors and are immediately exercisable on date of grant. Read SEC document |
| August 18, 2005 Filed Aug 19, 2005 01:00 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001179110-05-016670 · edgar.xml · derivative · entry 4 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2006-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vested 5% every quarter beginning date of grant on 1/2/1996. The options were fully vested as of 1/2/2001. Read SEC document |
| August 18, 2005 Filed Aug 19, 2005 01:00 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 16,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001179110-05-016670 · edgar.xml · derivative · entry 3 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2006-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested 5% every quarter beginning date of grant on 1/22/1996. The options were fully vested as of 1/22/2001. Read SEC document |
| August 18, 2005 Filed Aug 19, 2005 01:00 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 200,000 | $4.00 | $800,000.00 |
DisclosureSEC source: 0001179110-05-016670 · edgar.xml · nonDerivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2005 Filed Aug 19, 2005 01:00 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 16,000 | $4.75 | $76,000.00 |
DisclosureSEC source: 0001179110-05-016670 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2005 Filed May 12, 2005 20:27 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $38.87 | $0.00 |
DisclosureSEC source: 0001179110-05-009679 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2015-05-10 Read SEC document |
| March 02, 2005 Filed Mar 3, 2005 17:52 UTC | INTEL CORP INTC · Entity 2799 | GiftCOMMON | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000050863-05-000068 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · DIRECTOR EMERITUS 10b5-1 filing: Not disclosed Ownership: Indirect · Trust for Self and Spouse Disclosed balance after: 172,989,055 F1 · price: Not a required reportable field. SEC software requires a dollar amount; use zeros per SEC. Read SEC document |
| November 09, 2004 Filed Nov 12, 2004 19:34 UTC | INTEL CORP INTC · Entity 2799 | GiftCOMMON | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000050863-04-000227 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · DIRECTOR EMERITUS 10b5-1 filing: Not disclosed Ownership: Indirect · Trust for Self and Spouse Disclosed balance after: 174,244,255 F1 · price: Not a required reportable field. SEC software requires a dollar amount; use zeros per SEC. Read SEC document |
| November 01, 2004 Filed Nov 3, 2004 23:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 770 | $34.92 | $26,888.40 |
DisclosureSEC source: 0001179110-04-020687 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 0 Read SEC document |
| May 25, 2004 Filed May 27, 2004 23:02 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $62.80 | $0.00 |
DisclosureSEC source: 0001179110-04-011733 · edgar.xml · derivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2014-05-25 F1 · derivative.exercise_date: Options vest 100% on date of grant. Read SEC document |
| April 30, 2004 Filed May 28, 2004 20:19 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | OtherCommon Stock | 385 | $61.65 | $23,735.25 |
DisclosureSEC source: 0001179110-04-011784 · edgar.xml · nonDerivative · entry 2 MOORE GORDON EARLE · CIK 0000908567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Investment Partnership Disclosed balance after: 385 F1 · kind: Shares purchased by Moore Investment Partnership, a fully discretionary account. Read SEC document |
| June 17, 2003 Filed Jun 19, 2003 19:21 UTC | INTEL CORP INTC · Entity 2799 | GiftCOMMON | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000050863-03-000189 · edgar.xml · nonDerivative · entry 1 MOORE GORDON EARLE · CIK 0000908567 · DIRECTOR EMERITUS 10b5-1 filing: Not disclosed Ownership: Indirect · TRUST FOR SELF/SPOUSE Disclosed balance after: 175,244,255 F1 · price: Column 4 is not a required reportable field. New SEC software requires a dollar amount; use zeros per SEC. F2 · balance_after: Dr. Moore owns directly 3,302 shares of Intel Corporation common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.